RNA Medicine, the Next Frontier: Therapeutic Targeting of Non-Coding RNAs
December 13 @ 15:00 – 16:00 CET
Department of Nutritional Sciences & Toxicology, University of California, Berkeley
Anders M. Näär is a Professor of Metabolic Biology in the Department of Nutritional Sciences & Toxicology at the University of California, Berkeley. He was a postdoctoral research fellow with Robert Tjian at UC Berkeley/HHMI, where he discovered the human Mediator transcriptional co-activator complex. Dr. Näär was a Professor in the Department of Cell Biology, Harvard Medical School and the Massachusetts General Hospital Cancer Center. A major focus of his lab is to understand transcriptional and microRNA regulatory mechanisms controlling metabolic homeostasis to guide novel therapeutic strategies for the treatment of cardiovascular disease, obesity, Type 2 diabetes, non-alcoholic fatty liver diseases (NAFLD/NASH), age-related macular degeneration (AMD), Duchenne muscular dystrophy (DMD), multi-drug resistant fungal infections, and numerous types of cancer. His work resulted in a number of impactful studies, patents and foundation of companies. In his talk, Anders will broadcast his latest ventures in using RNA therapeutics in combating human diseases.
Date: 13 December 2021
Venue (format hybrid): SciLifeLab, lunchroom, y2
The ZOOM link is:
Meeting ID: 683 5317 5106